Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

LHRH antagonist with low-histamine releasing function

A technology of CH2 and peptide derivatives, applied in the field of decapeptide derivatives, can solve problems such as allergic reactions, and achieve the effect of low histamine release side effects

Inactive Publication Date: 2007-09-19
INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006]Most drugs will cause side effects of histamine release more or less in the body, and the LHRH antagonists currently developed are because they can trigger excessive histamine release and thus can Lead to the occurrence of allergic reactions, so it has not been well applied clinically

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • LHRH antagonist with low-histamine releasing function
  • LHRH antagonist with low-histamine releasing function
  • LHRH antagonist with low-histamine releasing function

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0319] Example 1: Boc-p-CH 2 Synthesis of Cl-Phe

[0320] Ac-Phe(p-CH 2 Cl)-Phe-OEt (prepared by our laboratory according to the conventional method, 5g, 17.6mmol) was refluxed in 40mL concentrated hydrochloric acid and 100mL dioxane for 10 hours, and then the hydrochloric acid and dioxane were evaporated to obtain a solid without separation and purification Add 50mL methanol directly under ice bath, adjust the pH of TEA to 9, then add 35.2mmol (3.9mL), then add 4.6g (Boc) 2 O (21.1 mmol), stir at room temperature for 12 hours, spin off methanol, adjust the pH of the aqueous solution to acidity, extract with ethyl acetate, wash the ester layer twice with water, and dry with anhydrous sodium sulfate. The ester layer was concentrated, and the oily substance was subjected to column chromatography and recrystallized from ethyl acetate-petroleum ether to obtain 2.7 g of white crystals. The total yield was 49.1%. TLC detection: chloroform: methanol: HOAc (20:1:0.5), Rf=0.6.

Embodiment 2

[0321] Example 2: Boc-Phe(NA B M) Synthesis

[0322] Boc-p-CH 2 Cl-Phe (prepared by our laboratory according to the conventional method) (1.75g, 5mmol) and dibenzyl iminodiacetate (1.88g, 6mmol, synthesized according to the method described in the following references: Huang Weide, Chen Changqing, peptide synthesis, science Press, 1985, p47) was placed in a 100ml round bottom flask, and 50ml ethanol was added to dissolve it. After adding TEA (1.69mL, 12mmol) under ice bath, stirring at room temperature for 72 hours, spin off the ethanol, adjust the pH of the aqueous solution to alkaline, wash with ether and then adjust the pH of the aqueous phase to acidic, extract with ethyl acetate, and wash twice with water. The layer was dried with anhydrous sodium sulfate. The ester layer was concentrated, and the solid was recrystallized with ethyl acetate-petroleum ether to obtain 1.80 g of white crystals with a yield of 61%. TLC detection: chloroform: methanol: HOAc (20:1:0.5), Rf=0.7.

Embodiment 3

[0323] Example 3: Boc-p-NH 2 (PhOCO)-Phe synthesis

[0324] Boc-p-NH 2 -Phe (1.40g, 5mmol, synthesized according to the method described in the following references: Theobald, P., Porter J., Rivier C., et al, J. Med. Chem., 1991, 34, 2395-2402) In a 150 mL round bottom flask, add 30 mL of water and 9.8 mL of 10% sodium carbonate aqueous solution to dissolve them, and then add 30 mL of 1,4-dioxane. Phenoxycarbonyl chloride (0.63 mL, 5 mmol) was added under ice bath. After 1 hour of reaction, 1,4-dioxane was spun off, and citric acid was acidified to acidity. It was extracted with ethyl acetate, and the ester layer was washed with water and saturated brine successively, and dried over anhydrous sodium sulfate. The ester layer was concentrated, 1.3 g of white crystals were obtained by column chromatography, and the yield was 65%. m.p. 260°C (decomposition), TLC detection: chloroform: methanol: acetic acid (9:1:0.5), Rf=0.8.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to decapeptide derivative which has LHRH receptor antagonism activity, an effect of inhibiting pituitary to excrete gonadotrophic hormone, an effect of inhibiting the gonad to excrete steroid hormone and has a lower histamine releasing effect, its producing method, the drug combination and its drug applications for treating the sex hormone correlated disease such as prostatecancer and the disease correlated to the anti-histamine or reducing histamine release.

Description

Technical field [0001] The present invention relates to decapeptide derivatives with LHRH receptor antagonistic activity and low histamine release side effects, and pharmaceutical compositions containing them and the decapeptide derivatives are used for preparing and treating prostate cancer and other related diseases of sex hormone dependence The use of drugs. Background technique [0002] LHRH (Luteinizing Hormone Releasing Hormone) is one of the peptide hormones secreted by the hypothalamus. Its main function is to promote the synthesis of the pituitary gland and release luteinizing hormone (LH) and follicle stimulating hormone (FSH) to stimulate pubertal development and regulate reproduction , Fertility and sex hormone related processes. LHRH consists of ten amino acid residues, and the C-terminal contains an amide structure. The primary structure of LHRH is as follows: [0003] p-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 [0004] LHRH antagonists inhibit the release of L...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K7/23A61K38/10A61P15/08A61K38/095
CPCA61K38/08G01N33/76G01N2333/59A61P15/08A61P35/00A61P5/24A61K38/095
Inventor 刘克良周宁林凡程周文霞张永祥程军平
Owner INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com